Citations

Showing 10 of 108083 citations.

Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer
Du, Meijun , Giridhar, Karthik V. , Tian, Yijun , Tschannen, Michael, Zhu, Jing , Huang, Chiang‐Ching , Kilari, Deepak , Kohli, Manish , Wang, Liang , Giridhar, Karthik V , Kohli, Manish

Mayo Clinic

Oncotarget | July 23, 2017 | Volume: 8 | Issue: 38 | Pages: 63703-63714

10.18632/oncotarget.19476 | PMID 28969022 Get It

Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study
Kinnunen, Kirsi M. , Cash, David M. , Poole, Teresa, Frost, Chris , Benzinger, Tammie L.S. , Ahsan, R. Laila, Leung, Kelvin K., Cardoso, M. Jorge , Modat, Marc , Malone, Ian B. , Morris, John C. , Bateman, Randall J. , Marcus, Daniel S. , Goate, Alison , Salloway, Stephen , Correia, Stephen , Chhatwal, Jasmeer P. , Mayeux, Richard , Martins, Ralph N. , Farlow, Martin R. , Saykin, Andrew J. , Jack, Clifford R. , Schofield, Peter R. , Weiner, Michael W. , Ringman, John M. , Thompson, Paul M. , Masters, Colin L. , Rossor, Martin N. , Ourselin, Sébastien , Fox, Nick C. , (DIAN), Dominantly Inherited Alzheimer Network, Sperling, Reisa Anne , Brickman, Adam M. , Ghetti, Bernardino , McDade, Eric , Rowe, Christopher Cleon , (DIAN), Dominantly Inherited Alzheimer Network, Jack, Clifford R , Saykin, Andrew J , Schofield, Peter R , Thompson, Paul M , Bateman, Randall J , Masters, Colin L , Benzinger, Tammie L S , Fox, Nick C , Morris, John C , Cash, David M , Goate, Alison M

Mayo Clinic

Alzheimer's & Dementia | July 22, 2017 | Volume: 14 | Issue: 1 | Pages: 43-53

10.1016/j.jalz.2017.06.2268 | PMID 28738187 Get It

Abstract Introduction Identifying at what point atrophy rates first change in Alzheimer's disease is important for informing design of presymptomatic trials. Methods Serial T1‐weighted magnetic resonance imaging scans of 94 participants (28 noncarriers, 66 carriers) from the Dominantly Inherited Alzheimer Network were used to measure brain, ventricular, and hippocampal atrophy rates. For each structure, nonlinear mixed‐effects models estimated the change‐points when atrophy rates deviate from normal and the rates of change before and after this point. Results Atrophy increased after the change‐point, which occurred 1–1.5 years (assuming a single step change in atrophy rate) or 3–8 years (assuming gradual acceleration of atrophy) before expected symptom onset. At expected symptom onset, estimated atrophy rates were at least 3.6 times than those before the change‐point. Discussion Atrophy rates are pathologically increased up to seven years before “expected onset”. During this period, atrophy rates may be useful for inclusion and tracking of disease progression.
Considerations in physical therapy management of a non-responding patient with low back pain
Madson, Timothy J.

Mayo Clinic

Physiotherapy Theory and Practice | July 22, 2017 | Volume: 33 | Issue: 9 | Pages: 743-750

10.1080/09593985.2017.1331480 | PMID 28727922 Get It

Response by Brinjikji et al to Letter Regarding Article, “Neurons Over Nephrons: Systematic Review and Meta-Analysis of Contrast-Induced Nephropathy in Patients With Acute Stroke”
Brinjikji, Waleed , Kallmes, David F. , Rabinstein, Alejandro A.

Mayo Clinic

Stroke | July 22, 2017 | Volume: 48 | Issue: 9 | Pages: No page available

10.1161/strokeaha.117.018458 | PMID 28733480 Get It

Serum Soluble Epidermal Growth Factor Receptor Concentrations Decrease in Postmenopausal Metastatic Breast Cancer Patients Treated with Letrozole
Lafky, Jacqueline M., Cora, Elsa M., Perez, Edith A. , Maihle, Nita J. , Baron, Andre T. , Hillman, David W. , Suman, Vera J. , Ingle, James N.

Mayo Clinic

Cancer Research | July 21, 2017 | Volume: 65 | Issue: 8 | Pages: 3059-3062

10.1158/0008-5472.can-05-0067 | PMID 15833834 Get It

Abstract Previous studies have implicated estrogen as a regulator of epidermal growth factor receptor (EGFR) expression in breast tumors. We therefore speculated that estrogen might modulate serologic soluble EGFR (sEGFR) concentrations in breast cancer patients. Accordingly, we measured serum sEGFR concentrations in postmenopausal women with metastatic breast cancer (MBC) treated with letrozole, an aromatase inhibitor that blocks estrogen synthesis. Serum specimens were obtained prior to and following 1 and 3 months of letrozole therapy. We report that sEGFR concentrations do not differ between MBC patients prior to letrozole treatment and age- and postmenopause-matched healthy women (P = 0.468). In contrast, however, sEGFR concentrations decreased significantly in 76% of MBC patients after both 1 month (P = 0.006) and 3 months (P = 0.003) of letrozole therapy versus pretreatment concentrations. Within the limitations of this study, we found no evidence for an association between pretreatment sEGFR concentrations or decreased treatment sEGFR concentrations and either progression-free or overall survival. Nonetheless, we conclude that future prospective studies are warranted to determine if baseline and/or longitudinal serum sEGFR concentrations may be useful for predicting disease progression and survival, and/or for monitoring responsiveness to aromatase inhibitors or other endocrine therapies in breast cancer patients.
Experimental Design and Analysis of Antibody Microarrays: Applying Methods from cDNA Arrays
Eckel‐Passow, Jeanette E. , Hoering, Antje , Therneau, Terry M. , Ghobrial, Irene M.

Mayo Clinic

Cancer Research | July 21, 2017 | Volume: 65 | Issue: 8 | Pages: 2985-2989

10.1158/0008-5472.can-04-3213 | PMID 15833819 Get It

Abstract Protein expression microarrays, also called antibody arrays, represent a new technology that allows the expression level of proteins to be assessed directly. As is also the case with gene expression microarrays, it is hoped that protein expression microarrays will aid in biomarker discovery, predicting disease outcomes and response to treatments, and detecting molecular mechanisms and/or pathways associated with a particular disease state. However, accurately achieving these aims is dependent upon suitable experimental designs, normalization procedures that eliminate systematic bias, and appropriate statistical analyses to assess differential expression or expose expression patterns. In the last five years, a large amount of research has been devoted to two-color cDNA arrays to improve experimental design, normalization and statistical analyses to assess differential expression and classification. These methods are directly applicable to two-color antibody arrays. The objective of this article is to discuss statistical methods that have been developed for cDNA arrays and describe how the methods can be directly applied to antibody arrays.
Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma
Connors, Joseph M. , Ansell, Stephen M. , Fanale, Michelle A. , Park, Steven I., Younes, Anas , Park, Steven , Connors, Joseph M , Park, Steven I

Mayo Clinic

Blood | July 21, 2017 | Volume: 130 | Issue: 11 | Pages: 1375-1377

10.1182/blood-2017-05-784678 | PMID 28733323 Get It

Upscaling Uncertainty with Dynamic Discrepancy for a Multi-Scale Carbon Capture System
Bhat, K. Sham , Mahapatra, Priyadarshi, Storlie, Curtis B. , Mebane, David S.

Mayo Clinic

Journal of the American Statistical Association | July 21, 2017 | Volume: 112 | Issue: 520 | Pages: 1453-1467

10.1080/01621459.2017.1295863 Get It

Local Cellular Responses to Titanium Dioxide from Orthopedic Implants
Yao, Jie , Lewallen, Eric A. , Trousdale, William H. , Xu, Wei , Thaler, Roman , Salib, Christopher G. , Reina, Nicolas , Lewallen, David G. , Wijnen, André J. van , Yao, Jie J, Abdel, Matthew P. , van Wijnen, Andre J

Mayo Clinic

BioResearch Open Access | July 21, 2017 | Volume: 6 | Issue: 1 | Pages: 94-103

10.1089/biores.2017.0017 | PMID 29034133 Get It

Social network analysis of a scientist–practitioner research initiative established to facilitate science dissemination and implementation within states and communities
Ginexi, Elizabeth M. , Huang, Grace C. , Steketee, Michael, Tsakraklides, Sophia, MacAllum, Keith, Bromberg, Julie , Huffman, Amanda, Luke, Douglas A. , Leischow, Scott J. , Rogers, Todd , Okamoto, Janet

Mayo Clinic

Research Evaluation | July 21, 2017 | Volume: 26 | Issue: 4 | Pages: 316-325

10.1093/reseval/rvx026 Get It